References

1. Burger M, Catto JWF, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234-241.

2. Alberg AJ, Hébert JR. Cigarette smoking and bladder cancer: a new twist in an old saga? J Natl Cancer Inst. 2010;102:1-2. Erratum.

3. Van Roekel EH, Cheng KK, James ND, et al. Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis. Int J Cancer. 2013;133:446-455.

4. Li S, Peng Q, Chen Y, et al. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis. PLoS One. 2013;8(9):e73448.

5. American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.

6. Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737-745.

7. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89(3):630-639.

8. Alberg AJ, Kouzis A, Genkinger JM, et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol. 2007;165(6):660-666.

9. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women’s Health Study. Cancer. 2002;95(11):2316-2323.

10. Baris D, Karagas MR, Verrill C, et al. A case–control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst. 2009;101:1553-1561.

11. Sexton WJ, Wiegand LR, Correa JJ, et al. Bladder cancer: a review of non–muscle invasive disease. Cancer Contr. 2010;17(4):256-268.

12. Jiang X, Castelao JE, Yuan J-M, et al. Cigarette smoking and subtypes of bladder cancer. Int J Cancer. 2012;130(4):896-901.

13. Welty CJ, Wright JL, Hotaling JM, et al. Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort. Urol Oncol. 2013;Mar 15: doi: 10.1016/j.urolonc.2012.009.001. [epub ahead of print]

This article originally appeared on Cancer Therapy Advisor